KIHARA JAMES (Principal Accounting Officer) sold 14.0% of their position (4.08K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $96.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/19/2025ACC: 0001816160-25-000004
Officer· Principal Accounting Officer
Since Jun 2020
-4.08K
Net shares
Net seller
$96.8K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
7.93K acquired · 12.02K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+3.97K
Price / share
—
Trade value
—
% of position
18.7%
11/17/2025
21.21K→25.18K
Common Stock
Direct
Shares
+3.97K
Price / share
—
Trade value
—
% of position
15.8%
11/17/2025
25.18K→29.14K
Common Stock
Direct
Shares
−4.08K
Price / share
$23.69
Trade value
$96.75K
% of position
14.0%
11/18/2025
29.14K→25.06K
Total
Net shares
+3.85K
Net value
-$96.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2025 | M · Option Exercise | +3.97K | — | — | 18.7% | 21.21K | 25.18K |
| Common Stock Direct | 11/17/2025 | M · Option Exercise | +3.97K | — | — | 15.8% | 25.18K | 29.14K |
| Common Stock Direct | 11/18/2025 | S · Sale | −4.08K | $23.69 | $96.75K | 14.0% | 29.14K | 25.06K |
| Total | +3.85K | -$96.75K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
3.97K shares
Shares
−3.97K
Strike price
Held after
0.00
Exercisable
—
11/17/2025
Restricted Stock Units
Direct
Converts to
Common Stock
3.97K shares
Shares
−3.97K
Strike price
Held after
0.00
Exercisable
—
11/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.97K shares | 11/17/2025 | M · Option Exercise | −3.97K | — | 0.00 | |
| Restricted Stock Units Direct | Common Stock3.97K shares | 11/17/2025 | M · Option Exercise | −3.97K | — | 0.00 |